FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014485354> ?p ?o ?g. }

• W2014485354 endingPage "231" @default.
• W2014485354 startingPage "227" @default.
• W2014485354 abstract "Objective: This study was conducted to determine whether to perform endovascular intervention or bypass surgery as a treatment option for critical limb ischemia (CLI) with lesions in the popliteal artery or below.Subjects and Methods: A total of 150 patients (164 limbs) with CLI underwent endovascular intervention or bypass surgery for lesions in the popliteal artery or below at our department between May 1995 and June 2011. Therapeutic outcomes were examined by surgical technique. An indication for endovascular intervention was established with the combination of (1) poor general condition, and (2) a stenotic or occlusive lesion ≤5 cm.Results: The bypass group (group B) comprised 119 patients (99 males, 20 females) with 131 affected limbs at 46 to 89 years of age (mean: 70 years). The endovascular intervention group (group E) comprised 31 patients (25 males, 6 females) with 33 affected limbs at 47 to 89 years of age (mean: 72 years). There was no significant difference in patient demography between the two groups. Regarding preoperative complications, hypertension was observed in 54% and 61% of the subjects in groups B and E, respectively, diabetes in 36% and 55%, renal dysfunction in 29% and 58%, ischemic heart disease in 27% and 32%, and cerebrovascular disorder in 18% and 23%; renal dysfunction accounted for a significantly higher percentage in group E. As for early postoperative complications, subjects in group B experienced wound infections (6 patients), hemorrhage (2), thrombosis (2), pneumonia (1), and another complication (1), and those in group E experienced wound infections (1) and another complication (1). The hospital mortality rate was 0.8% (1 patient) for group B and 0% for group E. The 3-year cumulative primary patency rate was 72% for group B and 54% for group E; the rate was significantly higher for group B. The 3-year secondary patency rate was 82% for group B and 60% for group E. The 3-year limb salvage rate was 86% for group B and 82% for group E; there was no significant difference between the two groups. The 5-year survival rate was 57% for group B and 42% for group E; the survival rate was significantly lower for group E.Conclusion: For the study population of CLI patients with lesions in the popliteal artery or below, the patency rate was higher for the bypass group than for the endovascular intervention group, whereas there was no difference in the limb salvage rate. Based on the findings in prognosis for survival, the indication for endovascular intervention at our department is believed to be appropriate. (*English translation of Jpn J Vasc Surg 2013; 22: 715-718)" @default.
• W2014485354 created "2016-06-24" @default.
• W2014485354 creator A5005382786 @default.
• W2014485354 creator A5018452114 @default.
• W2014485354 creator A5020055451 @default.
• W2014485354 creator A5036155605 @default.
• W2014485354 creator A5053746933 @default.
• W2014485354 creator A5055798666 @default.
• W2014485354 creator A5057163448 @default.
• W2014485354 creator A5071103658 @default.
• W2014485354 creator A5087328673 @default.
• W2014485354 creator A5091149024 @default.
• W2014485354 date "2014-01-01" @default.
• W2014485354 modified "2023-10-04" @default.
• W2014485354 title "Bypass vs. Endovascular Therapy of Infrapopliteal Lesions for Critical Limb Ischemia" @default.
• W2014485354 cites W1971655419 @default.
• W2014485354 cites W2052912940 @default.
• W2014485354 cites W2059957598 @default.
• W2014485354 cites W2144961144 @default.
• W2014485354 cites W2144985796 @default.
• W2014485354 cites W2147826941 @default.
• W2014485354 cites W2162412409 @default.
• W2014485354 cites W2185467918 @default.
• W2014485354 cites W4297067663 @default.
• W2014485354 doi "https://doi.org/10.3400/avd.oa.14-00070" @default.
• W2014485354 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4180682" @default.
• W2014485354 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25298822" @default.
• W2014485354 hasPublicationYear "2014" @default.
• W2014485354 type Work @default.
• W2014485354 sameAs 2014485354 @default.
• W2014485354 citedByCount "17" @default.
• W2014485354 countsByYear W20144853542015 @default.
• W2014485354 countsByYear W20144853542016 @default.
• W2014485354 countsByYear W20144853542017 @default.
• W2014485354 countsByYear W20144853542018 @default.
• W2014485354 countsByYear W20144853542019 @default.
• W2014485354 countsByYear W20144853542020 @default.
• W2014485354 countsByYear W20144853542021 @default.
• W2014485354 countsByYear W20144853542022 @default.
• W2014485354 crossrefType "journal-article" @default.
• W2014485354 hasAuthorship W2014485354A5005382786 @default.
• W2014485354 hasAuthorship W2014485354A5018452114 @default.
• W2014485354 hasAuthorship W2014485354A5020055451 @default.
• W2014485354 hasAuthorship W2014485354A5036155605 @default.
• W2014485354 hasAuthorship W2014485354A5053746933 @default.
• W2014485354 hasAuthorship W2014485354A5055798666 @default.
• W2014485354 hasAuthorship W2014485354A5057163448 @default.
• W2014485354 hasAuthorship W2014485354A5071103658 @default.
• W2014485354 hasAuthorship W2014485354A5087328673 @default.
• W2014485354 hasAuthorship W2014485354A5091149024 @default.
• W2014485354 hasBestOaLocation W20144853541 @default.
• W2014485354 hasConcept C126322002 @default.
• W2014485354 hasConcept C134018914 @default.
• W2014485354 hasConcept C141071460 @default.
• W2014485354 hasConcept C2776820930 @default.
• W2014485354 hasConcept C2777303625 @default.
• W2014485354 hasConcept C2777466421 @default.
• W2014485354 hasConcept C2777785397 @default.
• W2014485354 hasConcept C2777914695 @default.
• W2014485354 hasConcept C2779433084 @default.
• W2014485354 hasConcept C2780868729 @default.
• W2014485354 hasConcept C2781099653 @default.
• W2014485354 hasConcept C2781156865 @default.
• W2014485354 hasConcept C3018348675 @default.
• W2014485354 hasConcept C541997718 @default.
• W2014485354 hasConcept C555293320 @default.
• W2014485354 hasConcept C71924100 @default.
• W2014485354 hasConcept C81182388 @default.
• W2014485354 hasConceptScore W2014485354C126322002 @default.
• W2014485354 hasConceptScore W2014485354C134018914 @default.
• W2014485354 hasConceptScore W2014485354C141071460 @default.
• W2014485354 hasConceptScore W2014485354C2776820930 @default.
• W2014485354 hasConceptScore W2014485354C2777303625 @default.
• W2014485354 hasConceptScore W2014485354C2777466421 @default.
• W2014485354 hasConceptScore W2014485354C2777785397 @default.
• W2014485354 hasConceptScore W2014485354C2777914695 @default.
• W2014485354 hasConceptScore W2014485354C2779433084 @default.
• W2014485354 hasConceptScore W2014485354C2780868729 @default.
• W2014485354 hasConceptScore W2014485354C2781099653 @default.
• W2014485354 hasConceptScore W2014485354C2781156865 @default.
• W2014485354 hasConceptScore W2014485354C3018348675 @default.
• W2014485354 hasConceptScore W2014485354C541997718 @default.
• W2014485354 hasConceptScore W2014485354C555293320 @default.
• W2014485354 hasConceptScore W2014485354C71924100 @default.
• W2014485354 hasConceptScore W2014485354C81182388 @default.
• W2014485354 hasIssue "3" @default.
• W2014485354 hasLocation W20144853541 @default.
• W2014485354 hasLocation W20144853542 @default.
• W2014485354 hasLocation W20144853543 @default.
• W2014485354 hasLocation W20144853544 @default.
• W2014485354 hasOpenAccess W2014485354 @default.
• W2014485354 hasPrimaryLocation W20144853541 @default.
• W2014485354 hasRelatedWork W2035006751 @default.
• W2014485354 hasRelatedWork W2053556447 @default.
• W2014485354 hasRelatedWork W2090216898 @default.
• W2014485354 hasRelatedWork W2144099715 @default.
• W2014485354 hasRelatedWork W2323934732 @default.
• W2014485354 hasRelatedWork W2955145009 @default.

• next